Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence

This study has been completed.
Sponsor:
Collaborators:
State University of New York - Downstate Medical Center
Tibotec Pharmaceutical Limited
Information provided by (Responsible Party):
Anneli Uusküla, University of Tartu
ClinicalTrials.gov Identifier:
NCT01369056
First received: June 3, 2011
Last updated: May 24, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)